NovaBay Pharma (NBY) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $0.08 --0%
Revenue Growth %: -14.6%
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
WF, CWBC, GLTO, More
Revenue Growth %: -14.6%
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q2 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $3.59 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
